BLACK DIAMOND THERAPEUTICS I

Black Diamond Therapeutics’ Board Confident: Director Ali Buys Nearly 9,000 Shares Amid Steep Stock Decline

Black Diamond Therapeutics insider buying: Behbahani Ali’s $14.9k purchase signals board confidence amid a 52‑week low, hinting at future upside for investors.

BLACK DIAMOND THERAPEUTICS I
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

22/06/2026, 22:39

3 minutes to read

Prakash’s $1.66‑a‑share “buy the dip” move sparks insider confidence in Black Diamond Therapeutics amid steep market slide.

Raman Prakash’s latest share purchase at $1.66 shows insider confidence in Black Diamond Therapeutics’ cancer pipeline, offering a “buy the dip” signal amid market volatility.

BLACK DIAMOND THERAPEUTICS I
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

22/06/2026, 22:22

3 minutes to read